Literature DB >> 25998546

Factors affecting functional recovery after surgery and hand therapy in patients with Dupuytren's disease.

Christina Engstrand1, Barbro Krevers2, Joanna Kvist3.   

Abstract

STUDY
DESIGN: Prospective cohort study.
INTRODUCTION: The evidence of the relationship between functional recovery and impairment after surgery and hand therapy are inconsistent. PURPOSE OF THE STUDY: To explore factors that were most related to functional recovery as measured by DASH in patients with Dupuytren's disease.
METHODS: Eighty-one patients undergoing surgery and hand therapy were consecutively recruited. Functional recovery was measured by the Disability of the Arm, Shoulder and Hand (DASH) questionnaire. Explanatory variables: range of motion of the finger joints, five questions regarding safety and social issues of hand function, and health-related quality of life (Euroqol).
RESULTS: The three variables "need to take special precautions", "avoid using the hand in social context", and health-related quality of life (EQ-5D index) explained 62.1% of the variance in DASH, where the first variable had the greatest relative effect. DISCUSSION: Safety and social issues of hand function and quality of life had an evident association with functional recovery. LEVEL OF EVIDENCE: IV.
Copyright © 2015 Hanley & Belfus. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dupuytren's contracture; Emotional function; Quality of life; Range of motion; Recovery of function

Mesh:

Year:  2014        PMID: 25998546     DOI: 10.1016/j.jht.2014.11.006

Source DB:  PubMed          Journal:  J Hand Ther        ISSN: 0894-1130            Impact factor:   1.950


  3 in total

1.  Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.

Authors:  Jagdeep Nanchahal; Catherine Ball; Dominique Davidson; Lynn Williams; William Sones; Fiona E McCann; Marisa Cabrita; Jennifer Swettenham; Neil J Cahoon; Bethan Copsey; E Anne Francis; Peter C Taylor; Joanna Black; Vicki S Barber; Susan Dutton; Marc Feldmann; Sarah E Lamb
Journal:  EBioMedicine       Date:  2018-07-06       Impact factor: 8.143

2.  Collagenase Clostridium histolyticum Injection Therapy Improves Health-related Quality of Life in Patients with Dupuytren's Disease.

Authors:  Takuro Kuboi; Tsuyoshi Tajika; Fumitaka Endo; Wataru Goto; Ichiro Nakajima; Satoshi Hasegawa; Daisuke Nakajima; Takafumi Hasokawa; Hirotaka Chikuda
Journal:  Prog Rehabil Med       Date:  2021-05-26

3.  Return-to-Function Following Treatment of Dupuytren Contracture With Collagenase Clostridium Histolyticum Versus Fasciectomy.

Authors:  Victoria M Divino; Mitch DeKoven; David Hurley
Journal:  Hand (N Y)       Date:  2020-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.